The FDA has granted de novo classification to the Biolinq Shine wearable biosensor, which would be the first needle-free CGM ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them.

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ ...

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...

The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

Next presentation this afternoon is from DexCom, a leader in developing and commercializing continuous glucose monitoring systems for people with diabetes and I'm sure in the future beyond diabetes.

UBS analyst Danielle Antalffy reiterated a Buy rating on Dexcom today and set a price target of $106.00. The company’s shares opened today at $67.69. Take advantage of TipRanks Premium at 50% off!

Back in March we first heard that Sony was busy working on its first ever 200MP sensor for smartphone cameras, one meant for the main camera and one that could actually make its way to Samsung's ...

The global wearable medical devices market is set for unprecedented growth, with its size forecasted to surge from USD 42,981 ...

The first 21 satellites in a constellation that could become a cornerstone for the Pentagon's Golden Dome missile-defense shield successfully launched from California Wednesday aboard a SpaceX Falcon ...

Samsung’s new Galaxy Tab S11 has arrived with updated specs, the return of an 11-inch size, and some big S Pen changes. The Galaxy Tab S11 series will feel pretty similar to anyone who has seen the ...